Module 8: Harm Reduction – Topic E
Provide emergency services and administer naloxone in response to an overdose.
Learning Objectives
By the end of this topic, the student should be able to:
Describe the mechanism of opioid-induced respiratory depression
Describe the signs and symptoms of opioid overdose
Discuss the mechanism of action of naloxone
Identify the contents of a naloxone kit
Instruct others on the administration of naloxone
Stress the importance of calling 911 for all suspected opioid overdoses
Describe the “Good Samaritan” law in the context of opioid overdose
Key Concepts
Opioids exert several effects on the body. At high concentrations, opioids disrupt the respiratory centre in the brain, slow breathing, and reduce the sensitivity of the respiratory centre to changes in oxygen and carbon dioxide levels
A victim of an opioid overdose may have shallow, laboured breathing, or may not be breathing at all, may be unresponsive to verbal or physical stimuli, and will have small, pinpoint pupils
Naloxone is an opioid receptor antagonist or blocker. When an opioid is over-activating opioid receptors and causing respiratory depression, naloxone will compete with that opioid for receptor binding and “kick off” the opioid from the receptor, to reverse the overdose
A typical naloxone kit may contain, sterile gloves, two or more doses of naloxone, either an intramuscular form for injection into the arm or leg, or an intranasal form that is sprayed into a nostril. Often an instruction card, alcohol wipes, and a rescue breathing barrier are included
Naloxone is a short-acting drug and its effects may not last as long as many opioids. It is crucial to call 911 even if naloxone appears to reverse the overdose, because its effects may wear off
One barrier to calling 911 is a fear of consequences from law enforcement. The Good Samaritan legislation provides protection to those present at the overdose location, should they be in possession of drugs or drug parephenalia
An opioid overdose is a medical emergency, and regardless of the outcome, administering naloxone, calling 911, providing CPR, or being a bystander to the event may be very stressful and difficult
Opioids activate opioid receptors, μ, delta, and kappa, κ, throughout the body
In the respiratory centre (a collection of brain nuclei in the brainstem), μ opioid receptors play a key role in regulating breathing
Betts, J. G., Young, K. A., Wise, J. A., Johnson, E., Poe, B., Kruse, D. H., Korol, O., Johnson, J. E., Womble, M., & DeSaix, P. (2013). Anatomy and Physiology. OpenStax. https://openstax.org/books/anatomy-and-physiology/pages/1-introduction and licensed under (CC BY 4.0).
As the concentration of opioids in the brain increases, the function of the respiratory centre is disrupted, reducing its sensitivity to changes in pH, carbon dioxide, and oxygen
Normally, as breathing slows, carbon dioxide levels rise, and oxygen levels fall, the respiratory centre increases respiration without conscious control
In the presence of opioids, respiratory centre function is disrupted, and despite a reduction in breathing, the respiratory centre is “turned off” and cannot reverse the respiratory depression
Breathing continues to become more shallow, less frequent, and may eventually stop
Factors that increase the risk of an opioid overdose include: the dose of the opioid, the potency of the opioid, the presence of additional CNS depressions (e.g. alcohol, benzodiazepines), pre-existing cardiovascular disease, respiratory disease, obstructive sleep apnea, or any other factor that may impair breathing
Naloxone is an opioid receptor antagonist, i.e. blocker
Naloxone competes with opioids (agonists) for binding to opioid receptors, including µ opioid receptors in the respiratory centre
In OIRD, naloxone reverse the effects of the opioid at the respiratory centre, restoring normal physiological function/breathing
Naloxone also reverses other effects of opioids, including the effects of opioids on pain and euphoria, and administration can also result in shivering, muscle pain, nausea, vomiting, or diarrhea
In opioid-dependent individuals, naloxone may precipitate withdrawal symptoms.
1 mL ampoules or vials of naloxone hydrochloride 0.4 mg/mL intramuscular injection
Rescue breathing barrier
Pair of non-latex gloves
Training card and/or instructional insert
Alcohol swaps (for injectable naloxone)
Two safety syringes, 25g, 1 inch needle (for injectable naloxone)
Ampoule opening device (for injectable naloxone)
Depending on the jurisdiction, naloxone kits can be obtained (free of charge, often without a health card) from pharmacies, public health units, overdose prevention sites and other outreach services.
If a pharmacy doesn’t advertise, offer, or stock naloxone—ASK! One reason that pharmacies may not stock naloxone kits is that they don’t believe their patients and customers are interested in obtaining a kit.
Naloxone Administration
Intramuscular (IM) naloxone can be injected into a large muscle (shoulder, leg)
Intranasal naloxone (IN) is sprayed into a nostril
If there is no effect (no change in breathing, responsiveness) a second dose or additional doses may be administered
It is not possible to give too much naloxone.
When an overdose is suspected but not certain, naloxone should be given anyway.
9-1-1 should always be called, even if the overdose is successfully reversed with naloxone. The effects of naloxone can wear off more quickly than the effects of many opioids.
How to Administer Intranasal Naloxone:
Canadian Pharmacist’s Association. (2017). Administering Naloxone Nasal Spray. YouTube. https://youtu.be/aR3qA63TrAI
Used with permission from the Canadian Pharmacists Association
Fear of law enforcement can be a barrier to calling 911 in an opioid overdose, particularly if illicit drugs or drug parephenalia are present
The Good Samaritan Drug Overdose Act protects individuals at the scene of an opioid overdose from charges for possession of a controlled substance, breach of conditions related to drug charges, including pre-trial release, probation orders, conditional sentences, and parole violations
The Act does not provide protections for outstanding warrants, drug trafficking, or other crimes
Good Samaritan Drug Overdose Act: poster. (2018). [PDF]. Government of Canada. https://www.canada.ca/en/health-canada/services/substance-use/problematic-prescription-drug-use/opioids/toolkit/awareness-resources.html.
Wallet Card. (2015). [PDF]. Waterloo Region Crime Prevention Council. https://preventingcrime.ca/our-work/overdose-prevention/.
After the Overdose
Participation in an opioid overdose, whether the victim, administering naloxone, calling 911, or being a bystander at the scene, can be very stressful
In many cases, there is little to no follow-up or ability for individuals to discuss their feelings about being involved
Anyone feeling anxious or worried after being involved in an overdose/administering naloxone should speak to a health and social service professional or community supports
For people who have lost a loved one, health and social service professionals and community groups may be a source of information and support. Because of the opioid crisis, support groups specific to persons who have lost loved ones to overdose may be available
Now that you have reviewed this content, consider the following scenarios:
A group of policy makers has proposed that “everyone” should have a naloxone kit on hand. Do you agree or disagree with this statement? Why?
Consider this question in light of what you have learned above.
Questions
References
BC Centre for Disease Control. (2017). BC overdose prevention services guide, 2017. http://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/Other/BC%20Overdose%20Prevention%20Services%20Guide_Jan2019.pdf
Beazely, (n.d.). 5 counselling tips beyond the administration of take home naloxone. [Unpublished].
Boom, M., Niesters, M., Sarton, E., Aarts, L., Smith, T. W., & Dahan, A. (2012). Non-analgesic effects of opioids: Opioid-induced respiratory depression. Current Pharmaceutical Design, 18, 5994–6004.
Gupta, K., Nagappa, M., Prasad, A., Abrahamyan, L., Wong, J., Weingarten, T. N., & Chung, F. (2018). Risk factors for opioid-induced respiratory depression in surgical patients: A systematic review and meta-analyses. BMJ Open, 8, e024086.
Health Canada. (2019). About the Good Samaritan Drug Overdose Act. Government of Canada. https://www.canada.ca/en/health-canada/services/substance-use/problematic-prescription-drug-use/opioids/about-good-samaritan-drug-overdose-act.html
McAuley, A., Munro, A., & Taylor, A. (2018). “Once I’d done it once it was like writing your name”: Lived experience of take-home naloxone administration by people who inject drugs. International Journal of Drug Policy, 58, 46–54.
Pattinson, K.T. (2008). Opioids and the control of respiration. British Journal of Anaesthesia, 100, 747–758.
Wagner, K. D., Davidson, P. J., Iverson, E., Washburn, R., Burke, E., Kral, A. H., McNeeley, M., Jackson Bloom, J., & Lankenau, S. E. (2014). "I felt like a superhero": The experience of responding to drug overdose among individuals trained in overdose prevention. International Journal of Drug Policy, 25, 157–165.